Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Active Ulcerative Colitis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03518086
What this trial is testing

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,281
Large-scale testing (Phase 3)UnknownNCT03716388
What this trial is testing

Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC

Who this might be right for
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic Moderate
Dayanand Medical College and Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02888379
What this trial is testing

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Topivert Pharma Ltd 77
Testing effectiveness (Phase 2)Looking for participantsNCT06453317
What this trial is testing

Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisInflammatory Bowel Diseases
Medical University of Lodz 172
Early research (Phase 1)Looking for participantsNCT07665723
What this trial is testing

An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis

Who this might be right for
Active Ulcerative Colitis
Hoffmann-La Roche 25
Early research (Phase 1)Ended earlyNCT02000453
What this trial is testing

Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 2
Not applicableStudy completedNCT00951548
What this trial is testing

Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
VSL Pharmaceuticals 144
Not applicableStudy completedNCT05791526
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan

Who this might be right for
Ulcerative Colitis
AbbVie 308
Early research (Phase 1)Study completedNCT01900574
What this trial is testing

Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 35
Testing effectiveness (Phase 2)Ended earlyNCT05785715
What this trial is testing

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 81
Large-scale testing (Phase 3)Ended earlyNCT00537316
What this trial is testing

Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)

Who this might be right for
Ulcerative Colitis
Merck Sharp & Dohme LLC 242
Large-scale testing (Phase 3)Study completedNCT05767021
What this trial is testing

Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisUlcerative Colitis Chronic
Eli Lilly and Company 172
Large-scale testing (Phase 3)Active Not RecruitingNCT04624230
What this trial is testing

Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 118
Large-scale testing (Phase 3)Study completedNCT00269438
What this trial is testing

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 225
Testing effectiveness (Phase 2)WithdrawnNCT04898348
What this trial is testing

Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
KoBioLabs
Testing effectiveness (Phase 2)Study completedNCT00616434
What this trial is testing

Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Who this might be right for
Active Ulcerative Colitis
Biogen 123
Large-scale testing (Phase 3)Ended earlyNCT00984568
What this trial is testing

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)

Who this might be right for
Colitis, Ulcerative
Merck Sharp & Dohme LLC 28
Testing effectiveness (Phase 2)Study completedNCT01294410
What this trial is testing

Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 305
Large-scale testing (Phase 3)Study completedNCT00350415
What this trial is testing

A Double Blind Study for the Treatment of Acute Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Warner Chilcott 772
Post-approval studies (Phase 4)Study completedNCT01408810
What this trial is testing

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Grupo de Estudo da Doença Inflamatória Intestinal 21
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation